Legal Representation
Attorney
Amy B. Berge
USPTO Deadlines
Next Deadline
In Grace Period
Section 8 (6-Year) Declaration Due (Based on registration date 2019-02-12)
Due Date
February 12, 2025
Grace Period Ends
August 12, 2025
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
42 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 15, 2025 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| May 15, 2025 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| May 15, 2025 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jan 23, 2025 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| May 31, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| May 31, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| May 31, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Feb 12, 2024 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Sep 24, 2020 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Jul 15, 2020 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Jul 8, 2020 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Jun 18, 2020 | ASCK | I | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | Loading... |
| Feb 12, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jan 8, 2019 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jan 6, 2019 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Nov 28, 2018 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Nov 28, 2018 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 7, 2018 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Nov 7, 2018 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| May 11, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 9, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 9, 2018 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 9, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 7, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 3, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 3, 2017 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 3, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 9, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 14, 2017 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 14, 2017 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 22, 2017 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 2, 2017 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 1, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 1, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 1, 2017 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 1, 2017 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 11, 2016 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 11, 2016 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 11, 2016 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 10, 2016 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 10, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jun 7, 2016 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical product for the treatment of opioid dependence
First Use Anywhere:
Aug 15, 2018
First Use in Commerce:
Aug 15, 2018
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"US"